Study of Transplant Related Anemia Treated With Aranesp® (STRATA)

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

NCT00245895 ·Status: COMPLETED ·Phase: PHASE2

Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis

NCT00116701 ·Status: COMPLETED ·Phase: PHASE3

Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

NCT00355407 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia

NCT00117039 ·Status: COMPLETED ·Phase: PHASE4

Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)

NCT00093015 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis

NCT00111995 ·Status: COMPLETED ·Phase: PHASE4

Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure

NCT00213291 ·Status: COMPLETED ·Phase: PHASE3

A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)

NCT02241200 ·Status: COMPLETED ·Phase: PHASE1

Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients

NCT00204334 ·Status: COMPLETED ·Phase: PHASE4

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients

NCT00233597 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis

NCT00236964 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia

NCT00517881 ·Status: TERMINATED ·Phase: PHASE3

A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant

NCT00576602 ·Status: TERMINATED ·Phase: PHASE4

STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients

NCT00364845 ·Status: TERMINATED ·Phase: PHASE3

A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin

NCT01628120 ·Status: COMPLETED ·Phase: PHASE3

Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

NCT01290328 ·Status: TERMINATED ·Phase: NA

A Safety Study of Pentoxifylline for the Treatment of Anemia

NCT01102218 ·Status: TERMINATED ·Phase: PHASE2

An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant

NCT02538107 ·Status: COMPLETED

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

NCT00255437 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for Maintenance Treatment of Anemia in Kidney Transplant Recipients.

NCT00605345 ·Status: COMPLETED ·Phase: PHASE3

4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis

NCT01587898 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients

NCT02506868 ·Status: COMPLETED ·Phase: PHASE3

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

NCT00255424 ·Status: COMPLETED ·Phase: PHASE3

A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia

NCT02964936 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

NCT01628107 ·Status: COMPLETED ·Phase: PHASE3